Confirmation of COVID-19 was assessed by measuring the serological response (IgM, IgG, and IgA) to SARS-CoV-2 receptor binding domain (RBD) and/or nucleocapsid (N) proteins through ELISA. This evidence concerns the gene CD40LG and COVID-19.